What Valeris does

Valeris is a privately held life sciences commercialization platform headquartered in Morrisville, North Carolina, formed in May 2025 through the merger of Mercalis and PharmaCord. The company provides integrated end-to-end commercialization services to pharmaceutical and biotechnology manufacturers, operating across three service pillars: Insights and Data (strategy consulting and market access intelligence), Patient Support Services (access and affordability programs, non-commercial dispensing pharmacy, nursing support, patient engagement and adherence, eServices curation, and virtual clinical trial supply), and Healthcare Provider Engagement (contract sales teams, field reimbursement support, medical science liaisons, clinical nurse educators, and institutional sales support). Valeris also maintains two wholly-owned subsidiaries, Policy Reporter and Triangle Insights Group, which contribute market access data intelligence and consulting capabilities, respectively.

The platform is anchored by four proprietary technology products: Policy Reporter (described as the industry's leading source of market access policy and coverage data, including a first-in-market Medical Benefit Maximizer module), Valeris Vantage (an operational intelligence platform combining real-time guidance and data insights for patient support teams), the Valeris eServices Curator (a centralized contract service for acquiring eServices), and RxStudy Card (a virtual clinical trial supply solution). These products sit atop a digital patient engagement platform with web and iOS/Android mobile applications featuring behavior-based messaging, habit tracking, and symptom management. The company holds ISO 27001 certification for protected health information security management.

Valeris generates revenue primarily through professional services fees paid by life sciences brands under custom, quote-based B2B enterprise contracts negotiated for each commercialization engagement. The company reports serving 500+ life sciences partners, supporting 44M+ patients, and generating $34B+ in patient savings across its programs, with 10,000+ in-home nursing visits delivered through its field network. Valeris maintains 1,001–5,000 employees and operates exclusively in the United States, targeting pharmaceutical manufacturers seeking integrated commercialization partners across the product lifecycle.

Name

Valeris

Legal name

Valeris Incorporated

Website

https://valeris.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Valeris is a privately held US life sciences commercialization platform serving 500+ pharmaceutical and biotech manufacturers with integrated patient support, market access intelligence, and healthcare provider engagement services backed by proprietary technology including Policy Reporter and Valeris Vantage.

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercialization Services

NAICS

Management Consulting Services (54161), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Services-Management Consulting Services (8742), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Channel & Trade Strategy (Gross-to-Net, Distribution Economics) (HLAIAKAI)

akta.pro secondary industries

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

• Pharmaceutical commercialization services
• Patient support services
• Market access intelligence
• Healthcare provider engagement
• Life sciences consulting

Headquarters

HQ city

Morrisville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Commercialization Services: Integrated life sciences and pharmaceutical commercialization services including strategy consulting, market access intelligence, patient support services, and healthcare provider engagement. Revenue generated through service fees for these commercial partnership arrangements with pharmaceutical brands.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Valeris delivers integrated life sciences and pharmaceutical commercialization services spanning insights and data, patient support services, and healthcare provider engagement. Its offerings combine strategy consulting, market access intelligence (via Policy Reporter™), patient access and affordability programs, non-commercial dispensing pharmacy, nursing support, digital patient engagement, virtual clinical trial supply (RxStudy Card™), eServices acquisition, and HCP-facing field teams such as contract sales, field reimbursement, medical science liaisons, clinical nurse educators, and institutional sales support.

Product overview

Valeris is an integrated life sciences commercialization partner offering a platform-plus-services architecture combining proprietary technology products with comprehensive service offerings. The core technology products include Valeris Vantage™ (operational intelligence platform), Policy Reporter™ (market access intelligence), RxStudy Card™ (virtual clinical trial supply), and Valeris eServices Curator (eServices procurement). These are supported by three main service pillars: Insights and Data (Strategy Consulting, Market Access Intelligence), Patient Support Services (Patient Access and Affordability, Non-Commercial Dispensing Pharmacy, Nursing Support, Patient Engagement and Adherence), and Healthcare Provider Engagement (Contract Sales, Field Reimbursement, Medical Science Liaisons, Clinical Nurse Educators, Institutional Sales Support). The company was formed in May 2025 through the merger of Mercalis and PharmaCord.

Differentiator

Problem solved

Functional benefit

Brands

• Policy Reporter: Industry's leading source of market access policy and coverage data that integrates with Valeris patient support services programs, empowering agents and healthcare provider engagement teams to deliver fast, accurate information.
• Valeris Vantage
• RxStudy Card
• Valeris eServices Curator

Products and services

• End-to-End Commercialization Partnership Integrated life sciences and pharmaceutical commercialization partnership offering a seamless experience across insights, strategy, data, and solutions for pharmaceutical and biotech brands across the product lifecycle.
• Strategy Consulting Guidance from experienced life sciences advisors to help pharmaceutical and biotech clients navigate complex product, prescription, and patient journeys with tailored solutions.
• Market Access Intelligence On-demand access to Policy Reporter for market access policy and coverage data, integrated with Valeris patient support services programs to deliver fast, accurate information to patients and providers.
• Patient Access and Affordability Solutions for access and affordability integrated into patient support services programs, aligning financial assistance needs of patients with strategic business expectations of life science brands.
• Non-Commercial Dispensing Pharmacy Dispenses consigned products as free goods to patients in need, supporting QuickStart and Bridge programs and electronic prescription transmission from EMR systems.
• Nursing Support Services Multiple channels for clinical education and patient support including onsite and in-house nurse educators providing product and disease education combined with adherence and psychosocial support.
• Patient Engagement and Adherence End-to-end digital platform delivering patient support for specialty drug programs and clinical trials through text message alerts, copay enrollment, and ongoing adherence reminders.
• RxStudy Card™ Virtual Clinical Trial Supply Virtual clinical trial supply solution offering a more efficient and reliable way to procure commercially available clinical trial supplies, minimizing cost, time, and waste compared to traditional bulk procurement.
• Contract Sales Team Scalable and strategic outreach services to generate leads, educate, and engage healthcare providers across the value chain on behalf of life sciences clients.
• Field Reimbursement Support Reimbursement manager services supporting clinical trials and assisting healthcare providers with coverage and reimbursement processes.
• Medical Science Liaisons Expert liaison services connecting life sciences companies with healthcare providers through scientific communication and support.
• Clinical Nurse Educators Healthcare provider engagement strategies utilizing clinical nurse educators for product education and provider support.
• Institutional Sales Support Virtual HCP engagement services supporting institutional sales efforts and provider relationships.

Quantifiable outcome

• $34B+ in patient savings across 44M+ patients supported with 500+ life sciences partners
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• MercaliscoreStrategic or Co-development Partner · 1 May 2025Mercalis and PharmaCord finalized a merger in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.
• PharmaCordcoreStrategic or Co-development Partner · 1 May 2025PharmaCord merged with Mercalis in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Eversana: Eversana is an integrated life sciences commercialization services provider offering patient services, market access, HCP engagement, and consulting — a directly comparable full-stack commercialization platform to Valeris.
• Inizio: Inizio (formed from Ashfield and other agencies) provides commercialization, medical affairs, and patient engagement services to pharma — directly comparable to Valeris's HCP engagement and patient support service pillars.
• Syneos Health: Syneos Health offers clinical and commercial services including contract sales, patient solutions, and medical affairs — competing head-to-head with Valeris's HCP engagement and patient support offerings for pharma brand teams.
• ConnectiveRx: ConnectiveRx specializes in patient access, affordability, and adherence programs for pharma — closely overlapping with Valeris's patient support services and RxStudy Card clinical trial supply capabilities.
• OptimizeRx: OptimizeRx provides market access and affordability messaging through EHR workflows — comparable to Valeris's Policy Reporter market access intelligence and digital patient engagement platform offerings.

Broad incumbents

• IQVIA: IQVIA is the largest life sciences services conglomerate spanning R&D, real-world data, market access, and commercial/contract sales — overlapping with Valeris in market access intelligence and patient/HCP engagement as part of a much broader portfolio.
• Cencora (formerly AmerisourceBergen): Cencora is a top-tier pharmaceutical distributor with significant commercialization and patient services operations — a broader incumbent that overlaps with Valeris in specialty distribution and patient support adjacencies.
• Cardinal Health: Cardinal Health is a major pharmaceutical distributor and healthcare services operator with related patient and provider services — overlapping with Valeris's non-commercial dispensing pharmacy and patient access functions.
• McKesson: McKesson is a leading pharmaceutical distributor and biopharma services provider with US Bioservices and CoverMyMeds — comparable to Valeris in patient access, affordability, and HCP-facing services at much larger scale.

Emerging players

• Claritas Rx: Claritas Rx focuses on patient support program technology and specialty pharmacy analytics — an emerging niche player with partial overlap to Valeris's digital patient engagement and patient access offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/valeris

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valeris